Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea
- 주제(키워드) pulmonary disease , chronic obstructive , health care use , health care costs , drug prescriptions
- 등재 SCIE, SCOPUS
- 발행기관 INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
- 발행년도 2014
- 총서유형 Journal
- URI http://www.dcollection.net/handler/ewha/000000091077
- 본문언어 영어
- Published As http://dx.doi.org/10.5588/ijtld.13.0634
초록/요약
BACKGROUND: The prevalence and economic burden of chronic obstructive pulmonary disease (COPD) are increasing worldwide. However, little information is available concerning COPD-associated health care use and costs in Korea. OBJECTIVE: To analyse 1) health care use, medical costs and medication use in 2009, and 2) changes in costs and medication use over 5 years (2006-2010). DESIGN: Using the database of the Korean Health Insurance Review and Assessment Service, COPD patients were identified by searching on both ICD-10 codes and COPD medication. RESULTS: A total of 192 496 COPD patients were identified in 2009. Total medical costs per person were US$2803 +/- 3865; the average annual number of days of out-patient care and days of hospitalisation were respectively 40 +/- 36 and 11 +/- 33. Methylxanthine and systemic beta-agonists were the most frequently used drugs. However, the number of prescriptions for long-acting muscarinic antagonist increased rapidly. The total cost of COPD-related medications increased by 33.1% over 5 years. CONCLUSION: The present study provides new insight into health care use and the economic burden of COPD in Korea. Changing patterns of COPD-related medication use could help inform COPD management policies.
more